Dong Song is a medically-trained clinical research professional with over 10 years of experience in clinical practice as a cardiologist/physician and more than 20 years of clinical and pharmacology experience in both the hospital and clinical research organization setting. Don joined Everest in 2010 in the Data Management department and leads clinical trial safety data review and medical coding, and provides medical review of pharmacovigilance case safety reports. In his current role as Director of Clinical Safety Monitoring and Medical Coding, Don is also responsible for the strategic development of the Everest clinical trial scientific and medical training and educational programs, aiming to assist the clinical trial teams to gain in-depth understanding of the scientific and medical/clinical backgrounds of the trials that they are working on.

Before coming to Everest, Don was a Clinical Research Coordinator at the Heart Center of St. Paul’s Hospital in Vancouver British Columbia, Postdoctoral Fellow in Pharmaceutical Sciences at the University of British Columbia, Assistant Professor and Attending Doctor at the Medical School of Qingdao, China, and a Resident Physician at Qiqihar Medical School, Heilongjiang, China.

Don earned his Ph.D. in Pharmacology and Therapeutics from the University of British Columbia, British Columbia, Canada, his M.Sc. in Cardiology and Internal Medicine from Qingdao University Medical School, Qingdao, China, and a Bachelor of Medicine from Southeast University Medical College, Nanjing, China.